vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and Esquire Financial Holdings, Inc. (ESQ). Click either name above to swap in a different company.

Esquire Financial Holdings, Inc. is the larger business by last-quarter revenue ($40.5M vs $24.7M, roughly 1.6× Editas Medicine, Inc.). Esquire Financial Holdings, Inc. runs the higher net margin — 30.2% vs -22.7%, a 52.9% gap on every dollar of revenue. Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 15.0%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Esquire Financial Holdings, Inc. is a U.S.-headquartered bank holding company that provides comprehensive commercial and consumer banking products and services. Its core offerings include deposit accounts, business loans, mortgage services, and wealth management solutions, primarily serving small to medium enterprises, legal industry professionals, and local retail clients.

EDIT vs ESQ — Head-to-Head

Bigger by revenue
ESQ
ESQ
1.6× larger
ESQ
$40.5M
$24.7M
EDIT
Higher net margin
ESQ
ESQ
52.9% more per $
ESQ
30.2%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
15.0%
ESQ

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EDIT
EDIT
ESQ
ESQ
Revenue
$24.7M
$40.5M
Net Profit
$-5.6M
$12.2M
Gross Margin
Operating Margin
-31.3%
Net Margin
-22.7%
30.2%
Revenue YoY
-19.2%
Net Profit YoY
87.6%
7.0%
EPS (diluted)
$0.03
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
ESQ
ESQ
Q1 26
$40.5M
Q4 25
$24.7M
$39.4M
Q3 25
$7.5M
$37.6M
Q2 25
$3.6M
$35.8M
Q1 25
$4.7M
$33.8M
Q4 24
$30.6M
$33.1M
Q3 24
$61.0K
$31.9M
Q2 24
$513.0K
$30.6M
Net Profit
EDIT
EDIT
ESQ
ESQ
Q1 26
$12.2M
Q4 25
$-5.6M
$13.5M
Q3 25
$-25.1M
$14.1M
Q2 25
$-53.2M
$11.9M
Q1 25
$-76.1M
$11.4M
Q4 24
$-45.4M
$11.8M
Q3 24
$-62.1M
$11.4M
Q2 24
$-67.6M
$10.5M
Operating Margin
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
-31.3%
44.3%
Q3 25
-325.4%
46.5%
Q2 25
-1440.6%
42.5%
Q1 25
-1635.1%
45.9%
Q4 24
-152.2%
47.4%
Q3 24
-107649.2%
48.8%
Q2 24
-14016.2%
46.9%
Net Margin
EDIT
EDIT
ESQ
ESQ
Q1 26
30.2%
Q4 25
-22.7%
34.2%
Q3 25
-333.0%
37.4%
Q2 25
-1487.8%
33.2%
Q1 25
-1633.5%
33.8%
Q4 24
-148.3%
35.6%
Q3 24
-101870.5%
35.6%
Q2 24
-13178.8%
34.3%
EPS (diluted)
EDIT
EDIT
ESQ
ESQ
Q1 26
$1.40
Q4 25
$0.03
$1.54
Q3 25
$-0.28
$1.62
Q2 25
$-0.63
$1.38
Q1 25
$-0.92
$1.33
Q4 24
$-0.55
$1.35
Q3 24
$-0.75
$1.34
Q2 24
$-0.82
$1.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
ESQ
ESQ
Cash + ST InvestmentsLiquidity on hand
$146.6M
$222.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
$301.3M
Total Assets
$186.5M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
ESQ
ESQ
Q1 26
$222.2M
Q4 25
$146.6M
$235.9M
Q3 25
$165.6M
$240.8M
Q2 25
$178.5M
$163.0M
Q1 25
$221.0M
$173.0M
Q4 24
$269.9M
$126.3M
Q3 24
$265.1M
$147.7M
Q2 24
$279.1M
$152.7M
Total Debt
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Stockholders' Equity
EDIT
EDIT
ESQ
ESQ
Q1 26
$301.3M
Q4 25
$27.3M
$289.6M
Q3 25
$13.5M
$279.2M
Q2 25
$19.2M
$263.6M
Q1 25
$62.4M
$250.7M
Q4 24
$134.3M
$237.1M
Q3 24
$175.6M
$232.6M
Q2 24
$232.0M
$217.4M
Total Assets
EDIT
EDIT
ESQ
ESQ
Q1 26
$2.4B
Q4 25
$186.5M
$2.4B
Q3 25
$201.8M
$2.2B
Q2 25
$210.6M
$2.1B
Q1 25
$263.7M
$2.0B
Q4 24
$341.6M
$1.9B
Q3 24
$327.6M
$1.8B
Q2 24
$384.8M
$1.7B
Debt / Equity
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
ESQ
ESQ
Operating Cash FlowLast quarter
$-36.4M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
$-36.4M
$59.8M
Q3 25
$-30.8M
$16.8M
Q2 25
$-50.2M
$10.5M
Q1 25
$-47.8M
$15.8M
Q4 24
$-50.8M
$42.2M
Q3 24
$-52.6M
$10.5M
Q2 24
$-57.1M
$7.2M
Free Cash Flow
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
$-36.4M
$56.7M
Q3 25
$-31.3M
$16.2M
Q2 25
$9.3M
Q1 25
$-47.9M
$14.7M
Q4 24
$-51.3M
$41.5M
Q3 24
$-55.5M
$10.5M
Q2 24
$-60.6M
$6.9M
FCF Margin
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
-147.3%
143.9%
Q3 25
-414.6%
43.2%
Q2 25
26.0%
Q1 25
-1028.6%
43.4%
Q4 24
-167.6%
125.5%
Q3 24
-90998.4%
32.8%
Q2 24
-11804.3%
22.5%
Capex Intensity
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
0.2%
8.0%
Q3 25
5.7%
1.3%
Q2 25
0.0%
3.2%
Q1 25
2.4%
3.4%
Q4 24
1.8%
2.2%
Q3 24
4788.5%
0.2%
Q2 24
681.1%
1.1%
Cash Conversion
EDIT
EDIT
ESQ
ESQ
Q1 26
Q4 25
4.44×
Q3 25
1.19×
Q2 25
0.88×
Q1 25
1.39×
Q4 24
3.59×
Q3 24
0.93×
Q2 24
0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

ESQ
ESQ

Net Interest Income$34.0M84%
Noninterest Income$6.5M16%

Related Comparisons